EA200870263A1 - INTRAVENOUS METHOD OF TREATING VIRAL INFECTION - Google Patents
INTRAVENOUS METHOD OF TREATING VIRAL INFECTIONInfo
- Publication number
- EA200870263A1 EA200870263A1 EA200870263A EA200870263A EA200870263A1 EA 200870263 A1 EA200870263 A1 EA 200870263A1 EA 200870263 A EA200870263 A EA 200870263A EA 200870263 A EA200870263 A EA 200870263A EA 200870263 A1 EA200870263 A1 EA 200870263A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treating viral
- viral infection
- intravenous method
- intravenous
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
В настоящем изобретении предложены стандартные лекарственные формы, наборы и способы, применимые для лечения вирусных инфекций.The present invention provides unit dosage forms, kits, and methods useful for treating viral infections.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77274806P | 2006-02-13 | 2006-02-13 | |
PCT/US2006/013535 WO2007117241A1 (en) | 2006-04-12 | 2006-04-12 | Intramuscular antiviral treatments |
PCT/US2007/003755 WO2007095218A1 (en) | 2006-02-13 | 2007-02-12 | Intravenous antiviral treatments |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200870263A1 true EA200870263A1 (en) | 2009-06-30 |
EA025483B1 EA025483B1 (en) | 2016-12-30 |
Family
ID=38169715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200870263A EA025483B1 (en) | 2006-02-13 | 2007-02-12 | Intravenous method for treating a seasonal influenza |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1986626A1 (en) |
JP (3) | JP2009538822A (en) |
KR (9) | KR102475176B1 (en) |
AU (2) | AU2007215156A1 (en) |
BR (1) | BRPI0707769A2 (en) |
CA (1) | CA2642260C (en) |
EA (1) | EA025483B1 (en) |
HK (1) | HK1212250A1 (en) |
MX (2) | MX2008010394A (en) |
MY (1) | MY166063A (en) |
WO (1) | WO2007095218A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102475176B1 (en) * | 2006-02-13 | 2022-12-07 | 바이오크리스트 파마수티컬즈, 인코퍼레이티드 | Intravenous antiviral treatments |
CN101367750B (en) * | 2007-08-14 | 2012-05-23 | 中国人民解放军军事医学科学院毒物药物研究所 | (1S,2S,3S,4R)-3-[(1S)-1-acet-ammonia-2-ethyl-butyl]-4- guanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid aqua compound and medical uses thereof |
KR20220033561A (en) | 2020-09-07 | 2022-03-17 | 주식회사 경보제약 | Pharmaceutical composition of premix formulation containing peramivir compound |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU723360B2 (en) * | 1996-06-14 | 2000-08-24 | Biocryst Pharmaceuticals, Inc. | Substituted cyclopentane compounds useful as neuraminidase inhibitors |
ATE425955T1 (en) * | 1997-12-17 | 2009-04-15 | Biocryst Pharm Inc | SUBSTITUTED CYCLOPENTAN AND CYCLOPENTEN COMPOUNDS AS NEURAMINIDASE BLOCKERS |
GB0015324D0 (en) * | 2000-06-22 | 2000-08-16 | Biota Scient Management | Medicaments |
KR102475176B1 (en) * | 2006-02-13 | 2022-12-07 | 바이오크리스트 파마수티컬즈, 인코퍼레이티드 | Intravenous antiviral treatments |
-
2007
- 2007-02-12 KR KR1020217035812A patent/KR102475176B1/en active IP Right Grant
- 2007-02-12 KR KR1020227042429A patent/KR20230003248A/en not_active Application Discontinuation
- 2007-02-12 WO PCT/US2007/003755 patent/WO2007095218A1/en active Application Filing
- 2007-02-12 MX MX2008010394A patent/MX2008010394A/en active IP Right Grant
- 2007-02-12 EP EP07750583A patent/EP1986626A1/en not_active Ceased
- 2007-02-12 EA EA200870263A patent/EA025483B1/en unknown
- 2007-02-12 KR KR20147030611A patent/KR20140132778A/en not_active Application Discontinuation
- 2007-02-12 KR KR1020217018500A patent/KR102323339B1/en active IP Right Grant
- 2007-02-12 BR BRPI0707769-6A patent/BRPI0707769A2/en not_active Application Discontinuation
- 2007-02-12 KR KR1020087022406A patent/KR20080096829A/en active Application Filing
- 2007-02-12 AU AU2007215156A patent/AU2007215156A1/en not_active Abandoned
- 2007-02-12 KR KR1020167030296A patent/KR20160129105A/en not_active Application Discontinuation
- 2007-02-12 CA CA2642260A patent/CA2642260C/en active Active
- 2007-02-12 KR KR1020197017311A patent/KR102194015B1/en active IP Right Grant
- 2007-02-12 MX MX2020002008A patent/MX2020002008A/en unknown
- 2007-02-12 KR KR1020187005451A patent/KR101992585B1/en active IP Right Review Request
- 2007-02-12 KR KR1020207036259A patent/KR102267754B1/en active IP Right Grant
- 2007-02-12 JP JP2008554421A patent/JP2009538822A/en not_active Withdrawn
-
2008
- 2008-08-13 MY MYPI20083086A patent/MY166063A/en unknown
-
2013
- 2013-08-14 AU AU2013216632A patent/AU2013216632B2/en active Active
- 2013-08-26 JP JP2013174479A patent/JP6073202B2/en active Active
-
2015
- 2015-07-09 JP JP2015137495A patent/JP2015180695A/en not_active Withdrawn
-
2016
- 2016-01-14 HK HK16100369.5A patent/HK1212250A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR102267754B1 (en) | 2021-06-23 |
KR20140132778A (en) | 2014-11-18 |
JP2009538822A (en) | 2009-11-12 |
EP1986626A1 (en) | 2008-11-05 |
KR20190072681A (en) | 2019-06-25 |
CA2642260C (en) | 2016-08-09 |
AU2007215156A1 (en) | 2007-08-23 |
JP2015180695A (en) | 2015-10-15 |
MX2020002008A (en) | 2020-07-13 |
MY166063A (en) | 2018-05-23 |
EA025483B1 (en) | 2016-12-30 |
KR20200143519A (en) | 2020-12-23 |
KR20160129105A (en) | 2016-11-08 |
KR101992585B9 (en) | 2022-09-20 |
JP2013256527A (en) | 2013-12-26 |
KR102475176B1 (en) | 2022-12-07 |
KR20230003248A (en) | 2023-01-05 |
KR102323339B1 (en) | 2021-11-08 |
CA2642260A1 (en) | 2007-08-23 |
KR101992585B1 (en) | 2019-06-25 |
BRPI0707769A2 (en) | 2011-05-10 |
KR20210076189A (en) | 2021-06-23 |
HK1212250A1 (en) | 2016-06-10 |
WO2007095218A1 (en) | 2007-08-23 |
KR20180024027A (en) | 2018-03-07 |
AU2013216632A1 (en) | 2013-08-29 |
AU2013216632B2 (en) | 2016-09-01 |
MX2008010394A (en) | 2009-01-12 |
KR20210135632A (en) | 2021-11-15 |
KR102194015B1 (en) | 2020-12-22 |
KR20080096829A (en) | 2008-11-03 |
JP6073202B2 (en) | 2017-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201071315A1 (en) | HEPATITIS C VIRUS PROTEASE INHIBITORS | |
MA33806B1 (en) | INHIBITORS OF HEPATITIS C VIRUS | |
EA200900298A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA200971077A1 (en) | HETEROCYCLIC KINASE MODULATORS | |
EA200802182A1 (en) | MODIFIED HUMANIZED ANTIBODIES AGAINST INTERLEUKIN-18 | |
EA201170212A1 (en) | COOLING AND TREATMENT OF MATERIALS | |
EA201070247A1 (en) | PROTEAS INHIBITORS | |
EA200900802A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES | |
EA200802213A1 (en) | METHODS OF TREATING BLOOD DISEASES | |
CL2011002426A1 (en) | Compounds derived from substituted benzo-diazole pyrrolidine, inhibitors of the function of the ns5a protein encoded by the hepatitis c virus (vhc); pharmaceutical composition; and its use for the treatment of a vhc infection. | |
CL2011000838A1 (en) | Heterocyclic compounds derived from ortho-condensed tetracycles with a pyrimidine 2,4,6-trione spirocondensate group, bacterial DNA gyrase inhibitors; Preparation process; pharmaceutical composition; and its use for the treatment of a bacterial infection. | |
EA201390190A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA200901078A1 (en) | Conjugates of Synthetic Agonists TLR and Their Use | |
EA200600078A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES | |
EA200702048A1 (en) | PHARMACOKINETICALLY IMPROVED COMPOUNDS | |
BRPI0612124A2 (en) | heteroaryl derivatives for the treatment of viruses | |
EA200970805A1 (en) | SERINPROTEAS INHIBITORS FOR THE TREATMENT OF HCV INFECTIONS | |
EA200901241A1 (en) | CONNECTIONS FOR THE TREATMENT OF HEPATITIS C | |
EA200971096A1 (en) | THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION | |
NO20064547L (en) | Methods for treating HIV infection | |
ATE497492T1 (en) | CLEANING MONTELUKAST | |
WO2008115281A3 (en) | Compounds for treating viral infections | |
DE602005012481D1 (en) | 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8- (1H-INDOL-5-YL) -OCTANAMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF BLOOD HIGH PRESSURE | |
EA201000895A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIZOSOME DISEASES | |
EA201000948A1 (en) | VIRAL POLYMERASE INHIBITORS |